- Home
- SLS vs MAPS Comparison
SLS vs MAPS Comparison
Compare SLS & MAPS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SLS
- MAPS
- Stock Information
- Founded
- SLS 2012
- MAPS 2008
- Country
- SLS United States
- MAPS United States
- Employees
- SLS N/A
- MAPS N/A
- Industry
- SLS Biotechnology: Pharmaceutical Preparations
- MAPS Computer Software: Prepackaged Software
- Sector
- SLS Health Care
- MAPS Technology
- Exchange
- SLS Nasdaq
- MAPS Nasdaq
- Market Cap
- SLS 75.3M
- MAPS 84.2M
- IPO Year
- SLS N/A
- MAPS N/A
- Fundamental
- Price
- SLS $1.32
- MAPS $0.99
- Analyst Decision
- SLS Buy
- MAPS Buy
- Analyst Count
- SLS 1
- MAPS 2
- Target Price
- SLS $3.00
- MAPS $2.61
- AVG Volume (30 Days)
- SLS 753.9K
- MAPS 938.4K
- Earning Date
- SLS 11-13-2024
- MAPS 11-12-2024
- Dividend Yield
- SLS N/A
- MAPS N/A
- EPS Growth
- SLS N/A
- MAPS N/A
- EPS
- SLS N/A
- MAPS N/A
- Revenue
- SLS N/A
- MAPS $183,311,000.00
- Revenue This Year
- SLS N/A
- MAPS N/A
- Revenue Next Year
- SLS N/A
- MAPS $9.09
- P/E Ratio
- SLS N/A
- MAPS N/A
- Revenue Growth
- SLS N/A
- MAPS N/A
- 52 Week Low
- SLS $0.50
- MAPS $0.70
- 52 Week High
- SLS $1.72
- MAPS $1.47
- Technical
- Relative Strength Index (RSI)
- SLS 60.02
- MAPS 67.26
- Support Level
- SLS $1.22
- MAPS $0.71
- Resistance Level
- SLS $1.39
- MAPS $1.15
- Average True Range (ATR)
- SLS 0.08
- MAPS 0.08
- MACD
- SLS 0.02
- MAPS 0.03
- Stochastic Oscillator
- SLS 72.00
- MAPS 64.82
About SLS SELLAS Life Sciences Group Inc.
SELLAS Life Sciences Group Inc is a late-stage clinical biopharmaceutical company focused on the development of novel therapeutics for a broad range of cancer indications. The company's product candidates currently include galinpepimut-S, or GPS, a peptide immunotherapy directed against the Wilms tumor 1, or WT1, antigen, and GFH009, a selective small molecule cyclin-dependent kinase 9, or CDK9, inhibitor.
About MAPS WM Technology Inc.
WM Technology Inc is a technology and software infrastructure provider to the cannabis industry. It comprises B2C platform Weedmaps, and B2B software WM Business. Its revenues are derived primarily from monthly subscriptions to Weedmaps for Business, featured and deal listings and other WM Ad solutions. The Weedmaps for Business subscriptions generally have one-month terms that automatically renew unless notice of cancellation is provided in advance. Featured and deal listings and other WM Ad solutions are offered as add-on products to the Weedmaps for Business subscriptions. Featured and deal listings provide customers with premium placement ad solutions and discount and promotion pricing tools. Other WM Ad solutions include banner ads and promotion tiles on our marketplace ads.